Personalized Medicine – News and Features

Researchers developed a method to enhance mesenchymal stromal cells (MSCs) for cartilage tissue regeneration by adding ascorbic acid during cell expansion. This study also highlights micro magnetic resonance relaxometry (µMRR) as a novel tool.

A research team has developed an imaging technology using holotomography, allowing for real-time, high-resolution observation of living organoids. This innovative technique eliminates the need for fluorescent staining.

Metabolic factors influence tissue immunity in an intricate interplay between nutrient availability, organelle biology and tissue-resident memory T (TRM) cell development.

Researchers have established the English National Lynch Syndrome Registry, the UK’s first comprehensive database for patients with Lynch syndrome. This initiative links genomic data with cancer diagnosis and treatment information.

Researchers have identified neurodevelopmental symptoms that are signs of underlying genetic disorders.

Researchers discovered that antiviral enzymes induce early mutations in bladder cancer, and standard chemotherapy causes additional mutations. The study highlights the role of complex DNA rearrangements in treatment resistance.

This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.

A collaborative study between UK and Italian researchers investigates the biological mechanisms of major depressive disorder (MDD), focusing on the immune system's involvement. The research highlights gene expression profiles linked to inflammation.

A multicenter study found that different KRAS mutations in pancreatic ductal adenocarcinoma affect patient survival outcomes. The KRAS-G12D mutation correlates with aggressive cancer.

An array of nanopillars that can breach the nucleus of cells without damaging the membrane could open new possibilities in gene therapy.